Bas Groot Koerkamp
Researcher Next ID · RN-033611
Researcher · Medicine
Rotterdam, Netherlands
- Works count
- 1,034
- Citation count
- 29,980
- H-index
- 82
- i10-index
- 394
Research interests
Publications
Pancreatic cancer
The Lancet · 2025 · 10.1016/s0140-6736(25)00261-2
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology · 2022 · 10.1016/j.jhep.2021.12.010
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials
European Journal of Cancer · 2021 · 10.1016/j.ejca.2021.10.023
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma
JAMA Surgery · 2020 · https://doi.org/10.1001/jamasurg.2020.1973
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.02274
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology & Hepatology · 2020 · https://doi.org/10.1038/s41575-020-0310-z
Textbook Outcome
Annals of Surgery · 2019 · 10.1097/sla.0000000000003451
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
The Lancet. Gastroenterology & hepatology · 2019 · https://doi.org/10.1016/s2468-1253(19)30004-4
Benchmarks in Pancreatic Surgery
Annals of Surgery · 2019 · 10.1097/sla.0000000000003223
Surgery for cholangiocarcinoma
Liver International · 2019 · https://doi.org/10.1111/liv.14089
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
JNCI Journal of the National Cancer Institute · 2019 · 10.1093/jnci/djz073
A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma
JAMA Surgery · 2019 · 10.1001/jamasurg.2019.0571
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer
JAMA Surgery · 2018 · https://doi.org/10.1001/jamasurg.2018.3617
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD)
Annals of Surgery · 2018 · https://doi.org/10.1097/sla.0000000000002979
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
British journal of surgery · 2018 · https://doi.org/10.1002/bjs.10870
The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels
Annals of Surgery · 2018 · 10.1097/sla.0000000000002660
Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?
Surgery · 2018 · 10.1016/j.surg.2018.01.004
Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial
The Lancet. Gastroenterology & hepatology · 2018 · 10.1016/s2468-1253(18)30234-6
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS)
Annals of Surgery · 2017 · https://doi.org/10.1097/sla.0000000000002620
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
British journal of surgery · 2017 · https://doi.org/10.1002/bjs.10676
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA)
Annals of Surgery · 2017 · https://doi.org/10.1097/sla.0000000000002561
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant
Journal of the American College of Surgeons · 2016 · 10.1016/j.jamcollsurg.2016.03.035
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)00172-8
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone
Cancer · 2015 · 10.1002/cncr.29824
Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection
Journal of the American College of Surgeons · 2015 · 10.1016/j.jamcollsurg.2015.09.005
Current projects
No projects listed.